Condition
Diabetes Mellitus Foot Ulcer
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
Early P 1 (1)
Trial Status
Completed2
Unknown2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07021222Not ApplicableRecruitingPrimary
Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaFoot)
NCT05564728CompletedPrimary
Diabetes Footcare Companion App for Patients and Carers
NCT05604352Not ApplicableUnknownPrimary
Safety Evaluation of the DiaSole Insole With Diabetic Foot Ulcers.
NCT03085550Not ApplicableCompletedPrimary
Platelet Rich Plasma and Autologous Fat Graft for Diabetic Ulcer
NCT03916211Early Phase 1UnknownPrimary
Clinical Study of Adipose-derived Stem Cells in the Treatment of Diabetic Foot
Showing all 5 trials